|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304.62 USD | -3.77% |
|
-3.91% | +0.27% |
| 08/05 | RBC Capital Adjusts BeOne Medicines PT to $425 From $423, Maintains Outperform Rating | MT |
| 07/05 | BeOne Medicines Shares Surge After Robust First-Quarter | DJ |
| Capitalization | 33.87B 29.01B 26.53B 25.12B 46.51B 3,238B 46.88B 317B 123B 1,539B 127B 124B 5,356B | P/E ratio 2026 * |
46.2x | P/E ratio 2027 * | 32x |
|---|---|---|---|---|---|
| Enterprise value | 30.02B 25.72B 23.51B 22.27B 41.22B 2,870B 41.56B 281B 109B 1,364B 113B 110B 4,747B | EV / Sales 2026 * |
4.64x | EV / Sales 2027 * | 3.97x |
| Free-Float |
0.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BeOne Medicines AG
| 1 day | -3.77% | ||
| 1 week | -3.91% | ||
| Current month | +3.17% | ||
| 1 month | -1.74% | ||
| 3 months | -11.98% | ||
| 6 months | -16.73% | ||
| Current year | +0.27% |
| 1 week | 301.07 |  | 322.45 |
| 1 month | 289.54 | | 328.39 |
| Current year | 271.47 | | 372.73 |
| 1 year | 227.05 | | 385.22 |
| 3 years | 126.97 | | 385.22 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 24.53 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 57 | 28/10/2010 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 50 | 22/07/2024 |
Xiao Bin Wu
PSD | President | 64 | 01/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 57 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 51 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 52 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.77% | -3.91% | +38.50% | +27.79% | 33.87B | |
| -0.34% | -2.34% | -16.72% | -19.28% | 42.28B | |
| -0.31% | +4.88% | +278.60% | +477.77% | 31.78B | |
| -0.99% | -4.46% | +20.35% | -9.30% | 28.49B | |
| +2.41% | -3.65% | +31.50% | +27.88% | 27.41B | |
| +0.78% | -0.26% | - | - | 15.25B | |
| -1.50% | -14.49% | +198.14% | +4,123.83% | 13.31B | |
| -2.47% | -0.45% | +132.15% | +113.12% | 12.51B | |
| -0.37% | -0.27% | +6.52% | -2.18% | 12.2B | |
| -1.08% | -2.23% | +43.68% | +100.61% | 11.97B | |
| Average | -0.76% | -2.70% | +81.41% | +537.80% | 22.91B | |
| Weighted average by Cap. | -0.74% | -2.41% | +73.83% | +342.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.47B 5.54B 5.07B 4.8B 8.88B 619B 8.96B 60.47B 23.49B 294B 24.28B 23.76B 1,023B | 7.4B 6.34B 5.79B 5.49B 10.16B 707B 10.24B 69.14B 26.86B 336B 27.76B 27.16B 1,170B |
| Net income | 740M 634M 580M 549M 1.02B 70.79B 1.02B 6.92B 2.69B 33.64B 2.78B 2.72B 117B | 1.08B 921M 842M 798M 1.48B 103B 1.49B 10.05B 3.9B 48.86B 4.04B 3.95B 170B |
| Net Debt | -3.85B -3.3B -3.01B -2.85B -5.29B -368B -5.33B -35.98B -13.98B -175B -14.44B -14.14B -609B | -4.5B -3.85B -3.52B -3.34B -6.18B -430B -6.23B -42.04B -16.33B -204B -16.88B -16.52B -711B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 304.62 $ | -3.77% | 261,909 |
| 13/05/26 | 316.55 $ | +0.47% | 181,667 |
| 12/05/26 | 315.07 $ | +1.39% | 268,362 |
| 11/05/26 | 310.75 $ | -0.44% | 346,710 |
| 08/05/26 | 312.12 $ | -1.54% | 210,369 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition